Member-only story

I’m Aware That I’m Rare: Scott Visovatti, MD (220)

phaware global association®
7 min readFeb 17, 2019

The phaware® interview

Scott Visovatti, MD discusses how early treatment of patients with abnormal exercise studies can delay, or even prevent, the development of pulmonary arterial hypertension. Dr. Visovatti is an Assistant Professor of Internal Medicine in the Division of Cardiology at the University of Michigan. As a physician-scientist in their Pulmonary Hypertension Program, he cares for patients in clinic, performs clinical research that investigates the role of exercise in the diagnosis of pulmonary hypertension, and runs a basic science research lab aimed at exploring the role of purinergic signaling in the development of pulmonary arterial hypertension.

My name is Dr. Scott Visovatti. I am a cardiologist and assistant professor of internal medicine at the University of Michigan. I’d like to talk a little bit about the role of exercise in the diagnosis, and perhaps even, predicting the future of patients with pulmonary hypertension.

What we know is that there are groups of folks who are at risk for developing pulmonary hypertension, or…

--

--

phaware global association®
phaware global association®

Written by phaware global association®

Are You #phaware? Pulmonary hypertension (PH) is a rare, life-threatening disease affecting the arteries of the lungs. www.phaware.global

No responses yet